Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is the reference for combination therapy based on protease inhibitors due to its efficacy, tolerability, and convenience. Head-to-head randomized comparisons between D/C/F/TAF and combination therapy based on integrase inhibitors i...

Descripción completa

Detalles Bibliográficos
Autores: Podzamczer, Daniel|||0000-0001-7090-3561, Micán, R., Tiraboschi, Juan Manuel|||0000-0002-0073-873X, Portilla, J., Domingo Pedrol, Pedro|||0000-0003-1138-5770, Llibre Codina, Josep Maria|||0000-0002-7158-6753, Ribera, E., Vivancos-Gallego, María J.|||0000-0002-9373-6011, Morano, L., Masiá, M., Gómez, C., Fanjul, F., Payeras, A., Inciarte, Alexy|||0000-0003-1896-3457, Estrada, Vicente|||0000-0002-7795-5986, Rivero-Juarez, Antonio|||0000-0002-5813-6889, Castro, A., Bernal, Enrique|||0000-0002-4041-0579, Vinuesa, D., Knobel Freud, Hernando|||0000-0003-3186-6416, Troya, Jesús|||0000-0001-7323-114X, Macías, Juan|||0000-0002-4778-790X, Montero, M., Sanz Sanz, Jesús, Navarro-Alcaraz, Antonio|||0000-0002-1118-8972, Caicedo, A., Fernández Rodríguez, Gonzalo, Martínez, Esteban|||0000-0002-6911-8846, Moreno, S.
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:286334
Acceso en línea:https://ddd.uab.cat/record/286334
https://dx.doi.org/urn:doi:10.1093/ofid/ofab595
Access Level:acceso abierto
Palabra clave:Darunavir/cobicistat
Dolutegravir
Naive patients
Tenofovir alafenamide
Virologic efficacy
id ES_3cc83522ca69449a7e809a4db8b0ddf2
oai_identifier_str oai:ddd.uab.cat:286334
network_acronym_str ES
network_name_str España
repository_id_str
spelling Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)A Multicenter Randomized Open-Label Study (PReEC/RIS-57)Podzamczer, Daniel|||0000-0001-7090-3561Micán, R.Tiraboschi, Juan Manuel|||0000-0002-0073-873XPortilla, J.Domingo Pedrol, Pedro|||0000-0003-1138-5770Llibre Codina, Josep Maria|||0000-0002-7158-6753Ribera, E.Vivancos-Gallego, María J.|||0000-0002-9373-6011Morano, L.Masiá, M.Gómez, C.Fanjul, F.Payeras, A.Inciarte, Alexy|||0000-0003-1896-3457Estrada, Vicente|||0000-0002-7795-5986Rivero-Juarez, Antonio|||0000-0002-5813-6889Castro, A.Bernal, Enrique|||0000-0002-4041-0579Vinuesa, D.Knobel Freud, Hernando|||0000-0003-3186-6416Troya, Jesús|||0000-0001-7323-114XMacías, Juan|||0000-0002-4778-790XMontero, M.Sanz Sanz, JesúsNavarro-Alcaraz, Antonio|||0000-0002-1118-8972Caicedo, A.Fernández Rodríguez, GonzaloMartínez, Esteban|||0000-0002-6911-8846Moreno, S.Darunavir/cobicistatDolutegravirNaive patientsTenofovir alafenamideVirologic efficacyDarunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is the reference for combination therapy based on protease inhibitors due to its efficacy, tolerability, and convenience. Head-to-head randomized comparisons between D/C/F/TAF and combination therapy based on integrase inhibitors in antiretroviral-naive patients are lacking. Adult (.Universitat Autònoma de Barcelona 22022-01-0120222022-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/286334https://dx.doi.org/urn:doi:10.1093/ofid/ofab595reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0001open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2863342026-06-06T12:50:31Z
dc.title.none.fl_str_mv Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
title Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
spellingShingle Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
Podzamczer, Daniel|||0000-0001-7090-3561
Darunavir/cobicistat
Dolutegravir
Naive patients
Tenofovir alafenamide
Virologic efficacy
title_short Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
title_full Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
title_fullStr Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
title_full_unstemmed Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
title_sort Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI)
dc.creator.none.fl_str_mv Podzamczer, Daniel|||0000-0001-7090-3561
Micán, R.
Tiraboschi, Juan Manuel|||0000-0002-0073-873X
Portilla, J.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Llibre Codina, Josep Maria|||0000-0002-7158-6753
Ribera, E.
Vivancos-Gallego, María J.|||0000-0002-9373-6011
Morano, L.
Masiá, M.
Gómez, C.
Fanjul, F.
Payeras, A.
Inciarte, Alexy|||0000-0003-1896-3457
Estrada, Vicente|||0000-0002-7795-5986
Rivero-Juarez, Antonio|||0000-0002-5813-6889
Castro, A.
Bernal, Enrique|||0000-0002-4041-0579
Vinuesa, D.
Knobel Freud, Hernando|||0000-0003-3186-6416
Troya, Jesús|||0000-0001-7323-114X
Macías, Juan|||0000-0002-4778-790X
Montero, M.
Sanz Sanz, Jesús
Navarro-Alcaraz, Antonio|||0000-0002-1118-8972
Caicedo, A.
Fernández Rodríguez, Gonzalo
Martínez, Esteban|||0000-0002-6911-8846
Moreno, S.
author Podzamczer, Daniel|||0000-0001-7090-3561
author_facet Podzamczer, Daniel|||0000-0001-7090-3561
Micán, R.
Tiraboschi, Juan Manuel|||0000-0002-0073-873X
Portilla, J.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Llibre Codina, Josep Maria|||0000-0002-7158-6753
Ribera, E.
Vivancos-Gallego, María J.|||0000-0002-9373-6011
Morano, L.
Masiá, M.
Gómez, C.
Fanjul, F.
Payeras, A.
Inciarte, Alexy|||0000-0003-1896-3457
Estrada, Vicente|||0000-0002-7795-5986
Rivero-Juarez, Antonio|||0000-0002-5813-6889
Castro, A.
Bernal, Enrique|||0000-0002-4041-0579
Vinuesa, D.
Knobel Freud, Hernando|||0000-0003-3186-6416
Troya, Jesús|||0000-0001-7323-114X
Macías, Juan|||0000-0002-4778-790X
Montero, M.
Sanz Sanz, Jesús
Navarro-Alcaraz, Antonio|||0000-0002-1118-8972
Caicedo, A.
Fernández Rodríguez, Gonzalo
Martínez, Esteban|||0000-0002-6911-8846
Moreno, S.
author_role author
author2 Micán, R.
Tiraboschi, Juan Manuel|||0000-0002-0073-873X
Portilla, J.
Domingo Pedrol, Pedro|||0000-0003-1138-5770
Llibre Codina, Josep Maria|||0000-0002-7158-6753
Ribera, E.
Vivancos-Gallego, María J.|||0000-0002-9373-6011
Morano, L.
Masiá, M.
Gómez, C.
Fanjul, F.
Payeras, A.
Inciarte, Alexy|||0000-0003-1896-3457
Estrada, Vicente|||0000-0002-7795-5986
Rivero-Juarez, Antonio|||0000-0002-5813-6889
Castro, A.
Bernal, Enrique|||0000-0002-4041-0579
Vinuesa, D.
Knobel Freud, Hernando|||0000-0003-3186-6416
Troya, Jesús|||0000-0001-7323-114X
Macías, Juan|||0000-0002-4778-790X
Montero, M.
Sanz Sanz, Jesús
Navarro-Alcaraz, Antonio|||0000-0002-1118-8972
Caicedo, A.
Fernández Rodríguez, Gonzalo
Martínez, Esteban|||0000-0002-6911-8846
Moreno, S.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Darunavir/cobicistat
Dolutegravir
Naive patients
Tenofovir alafenamide
Virologic efficacy
topic Darunavir/cobicistat
Dolutegravir
Naive patients
Tenofovir alafenamide
Virologic efficacy
description Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is the reference for combination therapy based on protease inhibitors due to its efficacy, tolerability, and convenience. Head-to-head randomized comparisons between D/C/F/TAF and combination therapy based on integrase inhibitors in antiretroviral-naive patients are lacking. Adult (.
publishDate 2022
dc.date.none.fl_str_mv 2
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/286334
https://dx.doi.org/urn:doi:10.1093/ofid/ofab595
url https://ddd.uab.cat/record/286334
https://dx.doi.org/urn:doi:10.1093/ofid/ofab595
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 RD16/0025/0001
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406398179180544
score 15,300719